SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-014683
Filing Date
2023-05-15
Accepted
2023-05-15 17:28:22
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zvra20230308b_10q.htm   iXBRL 10-Q 1000904
2 EXHIBIT 31.1 ex_485756.htm EX-31.1 14378
3 EXHIBIT 31.2 ex_485757.htm EX-31.2 14491
4 EXHIBIT 32.1 ex_485758.htm EX-32.1 7117
5 EXHIBIT 32.2 ex_485759.htm EX-32.2 7407
  Complete submission text file 0001437749-23-014683.txt   5589495

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kmph-20230331.xsd EX-101.SCH 57536
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20230331_cal.xml EX-101.CAL 46454
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20230331_def.xml EX-101.DEF 371818
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20230331_lab.xml EX-101.LAB 346509
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20230331_pre.xml EX-101.PRE 393835
57 EXTRACTED XBRL INSTANCE DOCUMENT zvra20230308b_10q_htm.xml XML 804145
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 23924567
SIC: 2834 Pharmaceutical Preparations